US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

4.75

+0.33007.47%

Post-market: 4.840.0859+1.81%19:54 EDT

Volume:897.24K

Turnover:4.22M

Market Cap:324.58M

PE:-2.16

High:4.82

Open:4.38

Low:4.31

Close:4.42

Loading ...

Overview Company News Filings

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Novartis' Gene Therapy Meets Primary Endpoint in SMA Study

U.S. RESEARCH ROUNDUP- Domino's Pizza, Honeywell, Walmart

Bain Capital Life Sciences Opportunities Iv, L.p. Reports 9.99% Passive Stake in Olema Pharmaceuticals Inc as of Dec 4 - SEC Filing

THOMSON REUTERS

Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Olema Pharmaceuticals: Promising Clinical Data and Growth Potential Warrant a Buy Rating

Olema Pharmaceuticals Advances Breast Cancer Treatments

Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination With Ribociclib at the San Antonio Breast Cancer Symposium

THOMSON REUTERS

Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium

Novartis Announces Positive Results From Late-Stage Study on Fabhalta

Olema Pharmaceuticals Cleared to Begin Testing Prospective Breast Cancer Candidate

MT Newswires Live

Olema Pharmaceuticals Shares Rise 8.9% on FDA Approval of Cancer Drug Application

BRIEF-Olema Oncology Announces FDA Clearance Of Investigational New Drug Application For OP-3136

Olema Pharmaceuticals Inc - Phase 1 Clinical Trial for Op-3136 to Start Early 2025

THOMSON REUTERS

Olema Oncology Announces FDA Clearance of Investigational New Drug Application for Op-3136, a Potent Kat6 Inhibitor

THOMSON REUTERS

Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion

Sector Update: Health Care Stocks Mixed Pre-Bell Monday

MT Newswires Live

Olema Partners With Novartis for Clinical Trial of Potential Breast Cancer Drug, Launches $250 Million Stock, Warrant Placement

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/OLMA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OLMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OLMA\",,,,,undefined,":{"symbol":"OLMA","market":"US","secType":"STK","nameCN":"Olema Pharmaceuticals, Inc.","latestPrice":4.75,"timestamp":1745265600000,"preClose":4.42,"halted":0,"volume":897236,"hourTrading":{"tag":"盘后","latestPrice":4.8359,"preClose":4.75,"latestTime":"19:54 EDT","volume":1786,"amount":8484.14,"timestamp":1745279689657},"delay":0,"floatShares":41105967,"shares":68333065,"eps":-2.204055,"marketStatus":"Not Yet Opened","change":0.33,"latestTime":"04-21 16:00:00 EDT","open":4.38,"high":4.8198,"low":4.31,"amount":4220998.5804268,"amplitude":0.115339,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.204055,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"listingDate":1605762000000,"exchange":"NASDAQ","adjPreClose":4.42,"preHourTrading":{"tag":"盘前","latestPrice":4.43,"preClose":4.42,"latestTime":"09:28 EDT","volume":100,"amount":443,"timestamp":1745242080091},"postHourTrading":{"tag":"盘后","latestPrice":4.8359,"preClose":4.75,"latestTime":"19:54 EDT","volume":1786,"amount":8484.14,"timestamp":1745279689657},"volumeRatio":1.153757,"impliedVol":3.4012,"impliedVolPercentile":0.968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OLMA\",,,,,undefined,":{"symbol":"OLMA","floatShares":41105967,"roa":"-24.43%","roe":"-39.07%","lyrEps":-2.204055,"volumeRatio":1.153757,"shares":68333065,"dividePrice":0,"high":4.8198,"amplitude":0.115339,"preClose":4.42,"low":4.31,"week52Low":2.86,"pbRate":"0.79","week52High":16.62,"institutionHeld":0,"latestPrice":4.75,"eps":-2.204055,"divideRate":0,"volume":897236,"delay":0,"ttmEps":-2.204055,"open":4.38,"prevYearClose":5.83,"prevWeekClose":4.42,"prevMonthClose":3.76,"prevQuarterClose":3.76,"fiveDayClose":3.77,"twentyDayClose":4.23,"sixtyDayClose":5.85},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OLMA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2500812146","title":"Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500812146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500812146?lang=en_us&edition=fundamental","pubTime":"2025-01-04 05:30","pubTimestamp":1735939801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250103:nTUAPQZGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","OLMA"],"gpt_icon":0},{"id":"2500121708","title":"Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500121708","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500121708?lang=en_us&edition=fundamental","pubTime":"2025-01-04 05:30","pubTimestamp":1735939800,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, Jan.  03, 2025  (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, develop","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/03/3004177/0/en/Olema-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","NDAQ","BK4139","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","IE00B64PRP62.GBP","BK4505","IE00B3QW5Z07.USD",".IXIC","LU2095319765.USD","BK4588","OLMA"],"gpt_icon":0},{"id":"2500454647","title":"Novartis' Gene Therapy Meets Primary Endpoint in SMA Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2500454647","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500454647?lang=en_us&edition=fundamental","pubTime":"2025-01-01 02:39","pubTimestamp":1735670340,"startTime":"0","endTime":"0","summary":"Novartis NVS announced positive top-line results from the late-stage STEER study on experimental candidate intrathecal onasemnogene abeparvovec .Intrathecal onasemnogene abeparvovec  is an investigational, one-time gene therapy for patients with spinal muscular atrophy .The STEER study is a phase III randomized, double-blind, sham-controlled study evaluating the clinical efficacy, safety and tolerability of a one-time dose of intrathecal onasemnogene abeparvovec  in treatment nave patients with SMA type 2, aged two to less than 18 years who were able to sit, but never walked independently.Shares of Novartis have lost 3.6% in the past year aginst the industry’s growth of 1.8%.Results showed that the study met its primary endpoint. Data from the study showed an increase from baseline across the study population in total Hammersmith Functional Motor Scale - Expanded  scores.The increase was primarily observed in patients treated with OAV101IT compared to sham controls, indicating better m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novartis-gene-therapy-meets-primary-183900439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","BK4532","BK4007","IE00BFTCPJ56.SGD","CAGR","BK4139","LU0320765992.SGD","LU0211331839.USD","OLMA","IE0002141913.USD","BK4585","IE00B2B36J28.USD","BK4588","IE0009355771.USD","IE00BJT1NW94.SGD","BK4578","LU0109394709.USD","IE00BJJMRZ35.SGD","PTCT","IE00B4R5TH58.HKD","BK4159","NVS","LU0889565916.HKD"],"gpt_icon":0},{"id":"2492813389","title":"U.S. RESEARCH ROUNDUP- Domino's Pizza, Honeywell, Walmart","url":"https://stock-news.laohu8.com/highlight/detail?id=2492813389","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492813389?lang=en_us&edition=fundamental","pubTime":"2024-12-17 15:19","pubTimestamp":1734419964,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Domino's Pizza, Honeywell, WalmartDec 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Domino's","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL4N3NI0GT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COGT","LU0471298694.HKD","ALGT","HON","ACI","BK4121","IE0008368304.USD","SNDX","BK4534","LU2360032135.SGD","TMDX","TLRY","LU1150488135.SGD","LW","ASTH","MD","HCSG","ALEC","MOFG","JACK","WEN","LU1585245621.USD","CMG","NPCE","TOL","DPZ","TXRH","RGEN","POST","CMCSA","LU0109391861.USD","RARE","LU2211815571.USD","BHLB","ZBH","LU2264538146.SGD","NBIX","BVS","OLMA","PLNT","WMT","COST","LU2324357040.USD","BK4602","LU0889565916.HKD","PRVA","AGL"],"gpt_icon":1},{"id":"2490490813","title":"Bain Capital Life Sciences Opportunities Iv, L.p. Reports 9.99% Passive Stake in Olema Pharmaceuticals Inc as of Dec 4 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2490490813","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490490813?lang=en_us&edition=fundamental","pubTime":"2024-12-12 05:35","pubTimestamp":1733952910,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC1FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OLMA","BK4139","BK4505"],"gpt_icon":0},{"id":"2490859738","title":"Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490859738","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490859738?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:46","pubTimestamp":1733921182,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Matthew Biegler maintained a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) today and set a price target of $30.0...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-buy-on-olema-pharmaceuticals-olma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-buy-on-olema-pharmaceuticals-olma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OPY","OLMA","BK4505","BK4127"],"gpt_icon":0},{"id":"2490183007","title":"Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2490183007","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490183007?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:37","pubTimestamp":1733917020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OLMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2024 06:37 ET (11:37 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA"],"gpt_icon":0},{"id":"2490377068","title":"Olema Pharmaceuticals: Promising Clinical Data and Growth Potential Warrant a Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2490377068","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490377068?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:17","pubTimestamp":1733915824,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) today and set a price target of $30....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/olema-pharmaceuticals-promising-clinical-data-and-growth-potential-warrant-a-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/olema-pharmaceuticals-promising-clinical-data-and-growth-potential-warrant-a-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OLMA"],"gpt_icon":0},{"id":"2490090382","title":"Olema Pharmaceuticals Advances Breast Cancer Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2490090382","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490090382?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:49","pubTimestamp":1733834982,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals ( ($OLMA) ) has provided an update. Olema Pharmaceuticals has announced FDA clearance for its Investigational New Drug applic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/olema-pharmaceuticals-advances-breast-cancer-treatments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/olema-pharmaceuticals-advances-breast-cancer-treatments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OLMA","BK4505"],"gpt_icon":0},{"id":"2490091004","title":"Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination With Ribociclib at the San Antonio Breast Cancer Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2490091004","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490091004?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:00","pubTimestamp":1733832001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA7KCNPR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OLMA","BK4505","BK4139"],"gpt_icon":0},{"id":"2490944940","title":"Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2490944940","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490944940?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:00","pubTimestamp":1733832000,"startTime":"0","endTime":"0","summary":"Palazestrant, in combination with ribociclib, demonstrated promising clinical activity, a safety profile consistent with ribociclib and endocrine therapy, and favorable tolerability in patients with ER+/HER2- advanced or metastatic breast cancer. With a median follow-up of 12 months, median progression-free survival  has not been reached. 6-month PFS rate was 73% in all patients, 81% in patients with ESR1 mutations, 70% in ESR1 wild-type patients, and 68% in patients with prior CDK4/6 inhibitor treatment; data continue to mature. SAN FRANCISCO, Dec. 10, 2024  -- Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced updated clinical results from the ongoing Phase 1b/2 study of palazestrant in combination with CDK4/6 inhibitor, ribociclib, in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative  advanced","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/V3ehgYx1htqvLLoXcPRLlA--~B/aD0xMTk3O3c9NDE2ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/82f34ea0e328e54b1bb3d463e0ef2d0e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/V3ehgYx1htqvLLoXcPRLlA--~B/aD0xMTk3O3c9NDE2ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/82f34ea0e328e54b1bb3d463e0ef2d0e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/olema-oncology-presents-updated-clinical-120000772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OLMA","BK4195","BK4505","PFS","BK4211","BK4139"],"gpt_icon":0},{"id":"2490870258","title":"Novartis Announces Positive Results From Late-Stage Study on Fabhalta","url":"https://stock-news.laohu8.com/highlight/detail?id=2490870258","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490870258?lang=en_us&edition=fundamental","pubTime":"2024-12-10 02:19","pubTimestamp":1733768340,"startTime":"0","endTime":"0","summary":"Novartis NVS announced positive top-line results from a late-stage study on Fabhalta  in adult patients with paroxysmal nocturnal hemoglobinuria .Fabhalta is an oral, Factor B inhibitor of the alternative complement pathway.APPULSE-PNH is a phase IIIB multicenter, single-arm, open-label study to evaluate the efficacy and safety of twice-daily oral Fabhalta monotherapy  in adults with PNH who were switched from anti-C5 therapies .Year to date, shares of Novartis have risen 0.7% compared with the industry’s growth of 9.5%.The APPULSE-PNH study enrolled 52 participants who received Fabhalta for 24 weeks.In the Phase IIIB APPULSE-PNH study, oral Fabhalta improved the average hemoglobin  level versus baseline in adult patients with PNH who were switched from anti-C5 therapies.The positive results reinforce Fabhalta's ability to benefit both patients previously treated with anti-C5 therapies studied in the APPULSE-PNH and APPLY-PNH trials and complement-inhibitor nave patients studied in the","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1GILAZNg_sZU4tvhUip3sw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f166d65586ad9d3236a947b8d942f4c9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1GILAZNg_sZU4tvhUip3sw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f166d65586ad9d3236a947b8d942f4c9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novartis-announces-positive-results-stage-181900274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0306806265.USD","SG9999002232.USD","BK4592","BK4534","LU0211331839.USD","LU0985481810.HKD","CAGR","LU1883839398.USD","LU1057294990.SGD","BK4581","LU1023059063.AUD","SGXZ57979304.SGD","BK4585","BK4578","IE00BFTCPJ56.SGD","SSI","IE00B19Z3581.USD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","LU1894683264.USD","BK4159","PTCT","SG9999001176.SGD","BK4533","IE00B19Z3B42.SGD","NVS","SG9999011175.SGD","IE00BBT3K403.USD","BK4599","LU0889565916.HKD","SG9999001176.USD","BK4139","SG9999002224.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4007","LU0225771236.USD","LU0321505868.SGD","LU0225284248.USD","SG9999013999.USD","PFE","LU0868494617.USD","LU0234572021.USD","BK4588","LU0321505439.SGD","OLMA","IE000M9KFDE8.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2490753497","title":"Olema Pharmaceuticals Cleared to Begin Testing Prospective Breast Cancer Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2490753497","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490753497?lang=en_us&edition=fundamental","pubTime":"2024-12-09 22:40","pubTimestamp":1733755246,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals  early Monday said the US Food and Drug Administration has cleared the investigational new drug application for the company's OP-3136 drug candidate to treat breast and other types of cancer.The company is expecting to begin phase 1 testing of OP-3136 early in 2025, Olema said.Price: 10.51, Change: +0.06, Percent Change: +0.57","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","OLMA","BK4139","OP.USD.HKCC"],"gpt_icon":0},{"id":"2490298721","title":"Olema Pharmaceuticals Shares Rise 8.9% on FDA Approval of Cancer Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2490298721","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490298721?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:52","pubTimestamp":1733748720,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals shares rose 5.3% in premarket trading Monday after its investigational new drug application for OP-3136 was approved by the Food and Drug Administration.Shares were trading around $11. The stock is down 26% on the year.OP-3136 is a novel small molecule that potently and selectively inhibits KAT6, a validated epigenetic target that is dysregulated in breast and other cancers, the company said.\"We expect to initiate the Phase 1 clinical trial early next year and are excited by OP-3136's potential in breast cancer and beyond,\" said David Myles, chief discovery and non-clinical development officer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OP.USD.HKCC","BK4505","BK4139","OLMA"],"gpt_icon":0},{"id":"2490726999","title":"BRIEF-Olema Oncology Announces FDA Clearance Of Investigational New Drug Application For OP-3136","url":"https://stock-news.laohu8.com/highlight/detail?id=2490726999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490726999?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:15","pubTimestamp":1733746510,"startTime":"0","endTime":"0","summary":"BRIEF-Olema Oncology Announces FDA Clearance Of Investigational New Drug Application For OP-3136Dec 9 (Reuters) - Olema Pharmaceuticals Inc OLMA.O:OLEMA ONCOLOGY ANNOUNCES FDA CLEARANCE OF INVESTIGATI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nTUA7M9PMH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA","BK4139","BK4505"],"gpt_icon":0},{"id":"2490972541","title":"Olema Pharmaceuticals Inc - Phase 1 Clinical Trial for Op-3136 to Start Early 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2490972541","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490972541?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:00","pubTimestamp":1733745601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nTUA7M9PMH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OLMA","BK4505","BK4139"],"gpt_icon":0},{"id":"2490725407","title":"Olema Oncology Announces FDA Clearance of Investigational New Drug Application for Op-3136, a Potent Kat6 Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2490725407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490725407?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:00","pubTimestamp":1733745601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nTUA7M9PMH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OLMA","BK4505","BK4139"],"gpt_icon":0},{"id":"2488978501","title":"Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2488978501","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488978501?lang=en_us&edition=fundamental","pubTime":"2024-12-04 02:37","pubTimestamp":1733251020,"startTime":"0","endTime":"0","summary":"Novartis NVS has entered into a global license and collaboration agreement with PTC Therapeutics PTCT for the latter’s Huntington's disease candidate to strengthen NVS’ neuroscience pipeline.NVS also announced a collaboration with Olema Pharmaceuticals, Inc. OLMA for a breast cancer drug.Year to date, shares of Novartis have risen 3.8% compared with the industry’s growth of 8.9%.Novartis will in-license PTC Therapeutics’ PTC518. The candidate is an oral disease-modifying therapy in development for Huntington's disease.Interim results, reported in June 2024, demonstrated that PTC518 treatment resulted in durable, dose-dependent reduction in blood and cerebrospinal fluid  mutant Huntingtin protein  levels as well as early signals of dose-dependent benefit on key clinical measurements at 12 months.Novartis will make an upfront payment of $1.0 billion to PTCT and the latter will also be eligible for up to $1.9 billion in development, regulatory and sales milestones. NVS will also share pro","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1GILAZNg_sZU4tvhUip3sw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f166d65586ad9d3236a947b8d942f4c9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1GILAZNg_sZU4tvhUip3sw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f166d65586ad9d3236a947b8d942f4c9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novartis-licenses-ptcts-huntingtons-disease-183700510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BBT3K403.USD","BK4505","LU0225771236.USD","LU0321505439.SGD","SG9999002232.USD","BK4568","BK4581","BK4007","IE00BJJMRZ35.SGD","LU1894683264.USD","LU0109394709.USD","LU0122379950.USD","LU1883839398.USD","LU0306807586.USD","SGXZ57979304.SGD","BK4534","CSF","BK4588","LU0234572021.USD","PFE","PTCT","LU0211331839.USD","SG9999003800.SGD","LU0058720904.USD","SG9999013999.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","BK4585","LU0306806265.USD","LU1066051498.USD","LU1894683348.USD","IE00BJT1NW94.SGD","LU0321505868.SGD","LU0225284248.USD","LU1066053197.SGD","IE0002270589.USD","BK4139","IE0002141913.USD","IE0009355771.USD","BK4599","LU0456855351.SGD","LU0985481810.HKD","BK4533","OLMA","BK4532","NVS","IE00B4R5TH58.HKD","IE00BLSP4452.SGD","BK4592"],"gpt_icon":1},{"id":"2488674756","title":"Sector Update: Health Care Stocks Mixed Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2488674756","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488674756?lang=en_us&edition=fundamental","pubTime":"2024-12-02 22:14","pubTimestamp":1733148871,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed pre-bell Monday as the iShares Biotechnology ETF  was up 0.2% and the Health Care Select Sector SPDR Fund  was 0.1% lower recently.PTC Therapeutics  shares advanced by over 17% after the company said it signed an exclusive global license and collaboration agreement for its PTC518 Huntington's disease program with a subsidiary of Novartis , and will receive a $1 billion upfront payment.Zai Lab  and NovoCure  said their phase 3 trial evaluating TTFields along with gemcitabine and nab-paclitaxel as a treatment for unresectable, locally advanced pancreatic adenocarcinoma achieved its primary endpoint, demonstrating a \"statistically significant\" improvement in median overall survival. NovoCure shares rose past 45% premarket.Olema Pharmaceuticals  shares were nearly 9% higher after the company said it has launched a clinical trial collaboration and supply agreement with Novartis  for a frontline metastatic breast cancer treatment.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","NVS","BK4531","BK4548","IE00BFTCPJ56.SGD","PTCT","NVCR","BK4534","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4581","BK4585","LU0211331839.USD","BK4526","BK4588","IE00BJT1NW94.SGD","LU0320765992.SGD","BK4007","BK4578","IBB","BK4505","IE0002141913.USD","BK4139","BK4082","ZLAB","BK4532","OLMA","IE00B2B36J28.USD","LU0889565916.HKD","XLV","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2488767176","title":"Olema Partners With Novartis for Clinical Trial of Potential Breast Cancer Drug, Launches $250 Million Stock, Warrant Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2488767176","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488767176?lang=en_us&edition=fundamental","pubTime":"2024-12-02 21:08","pubTimestamp":1733144923,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals  said Monday it has launched a  clinical trial collaboration and supply agreement with Novartis  for a frontline metastatic breast cancer treatment.The company said it is ready to launch a 1,000-patient phase 3 clinical trial of palazestrant in combination with ribociclib as a potential frontline treatment for ER+/HER2- metastatic breast cancer.Under the terms of the agreement, Novartis will provide Olema with ribociclib drug supply for the planned trial. The company said all clinical data and inventions from the trial will be owned jointly while Olema will keep global commercial and marketing rights to palazestrant.Olema said it has also entered into a securities purchase agreement for the private placement of about $250 million of common stock and pre-funded warrants to purchase common stock with institutional investors.Olema said it will issue 19.9 million shares of common stock at a price of $9.08 per share and pre-funded warrants to purchase up to an aggregat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","BK4585","BK4007","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4578","BK4588","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4532","LU0211331839.USD","NVS","BK4139","IE00B4R5TH58.HKD","OLMA","IE0002141913.USD","IE0009355771.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":82,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OLMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-18","symbol":"OLMA","fiscalQuarterEnding":"2024/12","expectedEps":-0.63,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2024-11-12","symbol":"OLMA","fiscalQuarterEnding":"2024/09","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.6},{"market":"US","date":"2024-08-06","symbol":"OLMA","fiscalQuarterEnding":"2024/06","expectedEps":-0.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2024-05-08","symbol":"OLMA","fiscalQuarterEnding":"2024/03","expectedEps":-0.53,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.56},{"market":"US","date":"2024-03-11","symbol":"OLMA","fiscalQuarterEnding":"2023/12","expectedEps":-0.49,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710129600000,"reportTimeType":"post","actualEps":-0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OLMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OLMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1712116800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OLMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OLMA","date":"2025-04-17","current":-2.248319,"percent":0.746061,"low":-160.371485,"twenty":-21.881158,"median":-5.42117,"eighty":-1.86024,"high":-0.908267,"avg":-18.068774,"sd":34.681011,"marketCap":291098856},"quantilePoints":[{"date":"2020-11-20","current":-137.689749,"twenty":-137.802379,"median":-95.594417,"eighty":-53.499085,"marketCap":1790930568},{"date":"2020-11-27","current":-146.541284,"twenty":-146.188172,"median":-138.298512,"eighty":-87.175351,"marketCap":1906062480},{"date":"2020-12-04","current":-144.187207,"twenty":-153.215092,"median":-145.658505,"eighty":-137.802379,"marketCap":1875443003},{"date":"2020-12-11","current":-127.355558,"twenty":-149.872303,"median":-138.298512,"eighty":-127.873455,"marketCap":1656513738},{"date":"2020-12-18","current":-129.474227,"twenty":-148.359808,"median":-134.564918,"eighty":-118.062839,"marketCap":1684071268},{"date":"2020-12-24","current":-151.543697,"twenty":-148.965983,"median":-136.065642,"eighty":-119.863708,"marketCap":1971128870},{"date":"2020-12-31","current":-141.480019,"twenty":-146.541284,"median":-137.689749,"eighty":-126.149093,"marketCap":1840230603},{"date":"2021-01-08","current":-124.20698,"twenty":-146.394154,"median":-135.31528,"eighty":-124.530665,"marketCap":1615560186},{"date":"2021-01-15","current":-122.971089,"twenty":-145.658505,"median":-132.210841,"eighty":-122.971089,"marketCap":1599484961},{"date":"2021-01-22","current":-132.269693,"twenty":-144.481467,"median":-129.474227,"eighty":-123.135875,"marketCap":1720431897},{"date":"2021-01-29","current":-124.913203,"twenty":-143.622229,"median":-130.842534,"eighty":-123.506642,"marketCap":1624746030},{"date":"2021-02-05","current":-139.479053,"twenty":-143.433902,"median":-128.6503,"eighty":-123.506642,"marketCap":1814204047},{"date":"2021-02-12","current":-140.067573,"twenty":-145.776209,"median":-132.240267,"eighty":-123.589035,"marketCap":1821858917},{"date":"2021-02-19","current":-157.840853,"twenty":-146.453006,"median":-134.491353,"eighty":-123.747935,"marketCap":2053035973},{"date":"2021-02-26","current":-117.468435,"twenty":-146.453006,"median":-132.269693,"eighty":-123.589035,"marketCap":1527911932},{"date":"2021-03-05","current":-110.818168,"twenty":-146.305876,"median":-129.209393,"eighty":-122.729797,"marketCap":1441411908},{"date":"2021-03-12","current":-138.655126,"twenty":-145.893913,"median":-128.944559,"eighty":-122.217785,"marketCap":1803487230},{"date":"2021-03-19","current":-78.972283,"twenty":-145.823291,"median":-128.797429,"eighty":-121.499791,"marketCap":1746945869},{"date":"2021-03-26","current":-54.335783,"twenty":-144.775726,"median":-127.061298,"eighty":-117.733268,"marketCap":1201961853},{"date":"2021-04-01","current":-61.306023,"twenty":-143.904718,"median":-126.531631,"eighty":-113.902008,"marketCap":1356150529},{"date":"2021-04-09","current":-58.542884,"twenty":-143.457443,"median":-126.340362,"eighty":-107.940309,"marketCap":1295027140},{"date":"2021-04-16","current":-64.425695,"twenty":-143.410362,"median":-125.854834,"eighty":-72.383534,"marketCap":1425160806},{"date":"2021-04-23","current":-55.334078,"twenty":-143.180839,"median":-125.178036,"eighty":-63.402443,"marketCap":1224045141},{"date":"2021-04-30","current":-50.003895,"twenty":-142.309831,"median":-124.20698,"eighty":-61.505682,"marketCap":1106136154},{"date":"2021-05-07","current":-38.505673,"twenty":-140.915041,"median":-123.721452,"eighty":-58.785327,"marketCap":851783990},{"date":"2021-05-14","current":-27.703592,"twenty":-139.832165,"median":-123.177071,"eighty":-57.03118,"marketCap":990874372},{"date":"2021-05-21","current":-27.637395,"twenty":-139.149482,"median":-122.691543,"eighty":-56.08993,"marketCap":988506692},{"date":"2021-05-28","current":-30.847966,"twenty":-138.643356,"median":-121.735199,"eighty":-53.833764,"marketCap":1103339206},{"date":"2021-06-04","current":-30.572144,"twenty":-138.494825,"median":-118.969159,"eighty":-53.376706,"marketCap":1093473869},{"date":"2021-06-11","current":-31.785762,"twenty":-137.915008,"median":-117.68913,"eighty":-46.70952,"marketCap":1136881349},{"date":"2021-06-18","current":-27.041618,"twenty":-137.670958,"median":-115.526321,"eighty":-38.601937,"marketCap":967197565},{"date":"2021-06-25","current":-33.164873,"twenty":-137.360384,"median":-110.950584,"eighty":-33.032479,"marketCap":1186208030},{"date":"2021-07-02","current":-29.424723,"twenty":-136.348131,"median":-107.139923,"eighty":-31.829894,"marketCap":1052434071},{"date":"2021-07-09","current":-29.358526,"twenty":-136.065642,"median":-79.489257,"eighty":-30.991394,"marketCap":1050066390},{"date":"2021-07-16","current":-26.986454,"twenty":-135.535975,"median":-67.576564,"eighty":-30.870032,"marketCap":965224498},{"date":"2021-07-23","current":-28.486927,"twenty":-134.564918,"median":-63.926548,"eighty":-30.494914,"marketCap":1018891927},{"date":"2021-07-30","current":-25.905231,"twenty":-134.417788,"median":-62.402365,"eighty":-29.799841,"marketCap":926552380},{"date":"2021-08-06","current":-28.83998,"twenty":-134.270658,"median":-61.306023,"eighty":-28.961342,"marketCap":1031519558},{"date":"2021-08-13","current":-21.003404,"twenty":-132.269693,"median":-59.478786,"eighty":-28.531059,"marketCap":1044289255},{"date":"2021-08-20","current":-21.583349,"twenty":-132.210841,"median":-58.328964,"eighty":-28.288335,"marketCap":1073124108},{"date":"2021-08-27","current":-23.613156,"twenty":-131.828304,"median":-57.036528,"eighty":-28.012513,"marketCap":1174046092},{"date":"2021-09-03","current":-23.056722,"twenty":-129.474227,"median":-56.56412,"eighty":-27.482934,"marketCap":1146380220},{"date":"2021-09-10","current":-22.962677,"twenty":-129.050493,"median":-56.047146,"eighty":-27.174013,"marketCap":1141704298},{"date":"2021-09-17","current":-21.457955,"twenty":-128.709152,"median":-54.80819,"eighty":-26.953355,"marketCap":1066889545},{"date":"2021-09-24","current":-22.312198,"twenty":-127.614506,"median":-53.499085,"eighty":-26.58265,"marketCap":1109362503},{"date":"2021-10-01","current":-22.805935,"twenty":-127.12015,"median":-52.463979,"eighty":-26.399504,"marketCap":1133911094},{"date":"2021-10-08","current":-21.465793,"twenty":-126.920053,"median":-49.576054,"eighty":-25.746357,"marketCap":1067279205},{"date":"2021-10-15","current":-24.067707,"twenty":-126.602253,"median":-40.41313,"eighty":-23.849253,"marketCap":1196646382},{"date":"2021-10-22","current":-21.771439,"twenty":-126.531631,"median":-38.505673,"eighty":-23.505003,"marketCap":1082475952},{"date":"2021-10-29","current":-21.160146,"twenty":-126.461009,"median":-33.413114,"eighty":-23.401554,"marketCap":1052082459},{"date":"2021-11-05","current":-21.857647,"twenty":-126.278567,"median":-32.767689,"eighty":-23.124121,"marketCap":1086762214},{"date":"2021-11-12","current":-18.022011,"twenty":-126.166749,"median":-31.896091,"eighty":-23.014402,"marketCap":1073913601},{"date":"2021-11-19","current":-15.180643,"twenty":-125.913686,"median":-31.201019,"eighty":-22.790261,"marketCap":904599318},{"date":"2021-11-26","current":-13.920036,"twenty":-125.801867,"median":-30.969328,"eighty":-22.528502,"marketCap":829481009},{"date":"2021-12-03","current":-6.983362,"twenty":-125.572344,"median":-30.870032,"eighty":-22.33571,"marketCap":416131584},{"date":"2021-12-10","current":-6.816615,"twenty":-125.12507,"median":-30.572144,"eighty":-21.943855,"marketCap":406195300},{"date":"2021-12-17","current":-6.416423,"twenty":-124.68368,"median":-30.489398,"eighty":-21.809057,"marketCap":382348217},{"date":"2021-12-23","current":-6.609849,"twenty":-124.401191,"median":-30.219092,"eighty":-21.633506,"marketCap":393874307},{"date":"2021-12-31","current":-6.243006,"twenty":-124.077506,"median":-29.424723,"eighty":-21.46109,"marketCap":372014482},{"date":"2022-01-07","current":-4.869011,"twenty":-123.871524,"median":-29.193033,"eighty":-21.371747,"marketCap":290139500},{"date":"2022-01-14","current":-4.462148,"twenty":-123.747935,"median":-28.83998,"eighty":-21.160146,"marketCap":265894966},{"date":"2022-01-21","current":-3.968578,"twenty":-123.589035,"median":-28.531059,"eighty":-21.042589,"marketCap":236483565},{"date":"2022-01-28","current":-3.921888,"twenty":-123.506642,"median":-28.415214,"eighty":-21.003404,"marketCap":233701405},{"date":"2022-02-04","current":-3.921888,"twenty":-123.135875,"median":-28.166973,"eighty":-20.35606,"marketCap":233701405},{"date":"2022-02-11","current":-3.328269,"twenty":-122.953434,"median":-28.045611,"eighty":-17.893949,"marketCap":198328233},{"date":"2022-02-18","current":-3.001445,"twenty":-122.806304,"median":-27.703592,"eighty":-16.672027,"marketCap":178853116},{"date":"2022-02-25","current":-3.068144,"twenty":-122.500274,"median":-27.482934,"eighty":-14.598696,"marketCap":182827630},{"date":"2022-03-04","current":-2.52257,"twenty":-121.794051,"median":-27.339506,"eighty":-7.750398,"marketCap":179344633},{"date":"2022-03-11","current":-2.472119,"twenty":-121.735199,"median":-27.019553,"eighty":-6.983362,"marketCap":175757740},{"date":"2022-03-18","current":-2.786038,"twenty":-121.14668,"median":-26.903707,"eighty":-6.523141,"marketCap":198076184},{"date":"2022-03-25","current":-2.505753,"twenty":-118.969159,"median":-26.6665,"eighty":-6.369734,"marketCap":178149002},{"date":"2022-04-01","current":-2.298342,"twenty":-118.292362,"median":-26.545138,"eighty":-6.269685,"marketCap":163402888},{"date":"2022-04-08","current":-2.018056,"twenty":-117.909824,"median":-26.401711,"eighty":-6.129618,"marketCap":143475706},{"date":"2022-04-14","current":-1.726559,"twenty":-117.556713,"median":-25.949362,"eighty":-5.90551,"marketCap":122751438},{"date":"2022-04-22","current":-1.597628,"twenty":-116.197233,"median":-25.590793,"eighty":-4.885019,"marketCap":113584934},{"date":"2022-04-29","current":-1.429645,"twenty":-115.596943,"median":-23.942313,"eighty":-4.552858,"marketCap":101642020},{"date":"2022-05-06","current":-1.250238,"twenty":-113.360571,"median":-23.593563,"eighty":-4.286064,"marketCap":88886943},{"date":"2022-05-13","current":-1.094131,"twenty":-111.430227,"median":-23.511273,"eighty":-4.128654,"marketCap":86203297},{"date":"2022-05-20","current":-1.144785,"twenty":-110.871135,"median":-23.428984,"eighty":-3.921888,"marketCap":90194190},{"date":"2022-05-27","current":-1.494299,"twenty":-109.476344,"median":-23.401554,"eighty":-3.792492,"marketCap":117731355},{"date":"2022-06-03","current":-1.701982,"twenty":-107.940309,"median":-23.182115,"eighty":-3.446993,"marketCap":134094018},{"date":"2022-06-10","current":-2.180664,"twenty":-95.983102,"median":-23.111582,"eighty":-3.194872,"marketCap":171807960},{"date":"2022-06-17","current":-1.828617,"twenty":-83.111643,"median":-23.025374,"eighty":-3.010102,"marketCap":144071251},{"date":"2022-06-24","current":-2.213589,"twenty":-79.282467,"median":-22.962677,"eighty":-2.868598,"marketCap":174402041},{"date":"2022-07-01","current":-2.117346,"twenty":-74.579784,"median":-22.76675,"eighty":-2.736708,"marketCap":166819344},{"date":"2022-07-08","current":-2.446598,"twenty":-67.825247,"median":-22.570822,"eighty":-2.671682,"marketCap":192760151},{"date":"2022-07-15","current":-2.380748,"twenty":-66.614814,"median":-22.414081,"eighty":-2.546114,"marketCap":187571989},{"date":"2022-07-22","current":-2.461795,"twenty":-64.325866,"median":-22.33571,"eighty":-2.506079,"marketCap":193957419},{"date":"2022-07-29","current":-2.542841,"twenty":-63.751846,"median":-21.990878,"eighty":-2.478846,"marketCap":200342848},{"date":"2022-08-05","current":-2.978468,"twenty":-62.995994,"median":-21.904669,"eighty":-2.506079,"marketCap":234664531},{"date":"2022-08-12","current":-1.70625,"twenty":-62.621633,"median":-21.834136,"eighty":-2.462808,"marketCap":162501544},{"date":"2022-08-19","current":-1.68944,"twenty":-61.990568,"median":-21.720498,"eighty":-2.448339,"marketCap":160900544},{"date":"2022-08-26","current":-1.744073,"twenty":-61.705341,"median":-21.583349,"eighty":-2.391641,"marketCap":166103795},{"date":"2022-09-02","current":-1.458297,"twenty":-61.220455,"median":-21.461874,"eighty":-2.381761,"marketCap":138886788},{"date":"2022-09-09","current":-1.773491,"twenty":-60.878182,"median":-21.422688,"eighty":-2.330094,"marketCap":168905546},{"date":"2022-09-16","current":-1.584375,"twenty":-59.80858,"median":-21.371747,"eighty":-2.298342,"marketCap":150894291},{"date":"2022-09-23","current":-1.20194,"twenty":-59.148992,"median":-21.195413,"eighty":-2.231073,"marketCap":114471531},{"date":"2022-09-30","current":-1.159914,"twenty":-58.542884,"median":-21.160146,"eighty":-2.203044,"marketCap":110469030},{"date":"2022-10-07","current":-1.164116,"twenty":-58.328964,"median":-21.022996,"eighty":-2.180622,"marketCap":110869280},{"date":"2022-10-14","current":-1.20194,"twenty":-57.901123,"median":-21.003404,"eighty":-2.061626,"marketCap":114471531},{"date":"2022-10-21","current":-1.470905,"twenty":-57.063268,"median":-20.658572,"eighty":-1.899533,"marketCap":140087538},{"date":"2022-10-28","current":-1.559159,"twenty":-57.009788,"median":-20.337251,"eighty":-1.85901,"marketCap":148492790},{"date":"2022-11-04","current":-1.416272,"twenty":-56.902828,"median":-18.045355,"eighty":-1.81972,"marketCap":134884287},{"date":"2022-11-11","current":-1.352398,"twenty":-56.56412,"median":-17.641828,"eighty":-1.794504,"marketCap":135572465},{"date":"2022-11-18","current":-1.052309,"twenty":-56.154106,"median":-16.748064,"eighty":-1.771405,"marketCap":105489818},{"date":"2022-11-25","current":-1.260371,"twenty":-56.068538,"median":-14.983881,"eighty":-1.754975,"marketCap":126347120},{"date":"2022-12-02","current":-1.092321,"twenty":-55.476692,"median":-14.173491,"eighty":-1.726559,"marketCap":109500837},{"date":"2022-12-09","current":-0.976287,"twenty":-55.291294,"median":-10.688479,"eighty":-1.713133,"marketCap":97868880},{"date":"2022-12-16","current":-0.932274,"twenty":-54.524746,"median":-7.383555,"eighty":-1.683556,"marketCap":93456759},{"date":"2022-12-23","current":-1.060312,"twenty":-53.666425,"median":-6.930003,"eighty":-1.643063,"marketCap":106292022},{"date":"2022-12-30","current":-0.980288,"twenty":-53.499085,"median":-6.713232,"eighty":-1.594008,"marketCap":98269982},{"date":"2023-01-06","current":-1.140335,"twenty":-53.455838,"median":-6.473117,"eighty":-1.581853,"marketCap":114314061},{"date":"2023-01-13","current":-1.660488,"twenty":-53.383837,"median":-6.409753,"eighty":-1.571465,"marketCap":166457317},{"date":"2023-01-20","current":-1.860547,"twenty":-53.009476,"median":-6.363064,"eighty":-1.57681,"marketCap":186512416},{"date":"2023-01-27","current":-1.884554,"twenty":-51.244633,"median":-6.27969,"eighty":-1.581013,"marketCap":188919027},{"date":"2023-02-03","current":-1.820535,"twenty":-49.918327,"median":-6.243006,"eighty":-1.585216,"marketCap":182501396},{"date":"2023-02-10","current":-1.816534,"twenty":-48.859421,"median":-6.112944,"eighty":-1.588578,"marketCap":182100294},{"date":"2023-02-17","current":-1.820535,"twenty":-45.115813,"median":-5.922852,"eighty":-1.590388,"marketCap":182501396},{"date":"2023-02-24","current":-1.640482,"twenty":-41.607519,"median":-5.409271,"eighty":-1.597628,"marketCap":164451807},{"date":"2023-03-03","current":-1.640482,"twenty":-39.218741,"median":-4.879016,"eighty":-1.597628,"marketCap":164451807},{"date":"2023-03-10","current":-1.508369,"twenty":-38.986994,"median":-4.682254,"eighty":-1.580465,"marketCap":158057499},{"date":"2023-03-17","current":-1.407553,"twenty":-38.505673,"median":-4.418794,"eighty":-1.567565,"marketCap":147493245},{"date":"2023-03-24","current":-1.39592,"twenty":-37.703471,"median":-4.288732,"eighty":-1.556458,"marketCap":146274292},{"date":"2023-03-31","current":-1.345512,"twenty":-33.661354,"median":-4.222033,"eighty":-1.543267,"marketCap":140992165},{"date":"2023-04-06","current":-1.248573,"twenty":-33.264169,"median":-4.11865,"eighty":-1.524739,"marketCap":130834228},{"date":"2023-04-14","current":-1.469594,"twenty":-33.032479,"median":-3.948568,"eighty":-1.512794,"marketCap":153994324},{"date":"2023-04-21","current":-1.597553,"twenty":-32.814027,"median":-3.921888,"eighty":-1.508429,"marketCap":167402801},{"date":"2023-04-28","current":-1.795309,"twenty":-32.352852,"median":-3.8085,"eighty":-1.511486,"marketCap":188124993},{"date":"2023-05-05","current":-2.466505,"twenty":-32.054965,"median":-3.488347,"eighty":-1.512794,"marketCap":258457661},{"date":"2023-05-12","current":-2.51514,"twenty":-31.829894,"median":-3.328269,"eighty":-1.518065,"marketCap":276773559},{"date":"2023-05-19","current":-2.478153,"twenty":-31.785762,"median":-3.194872,"eighty":-1.520938,"marketCap":272703359},{"date":"2023-05-26","current":-1.983895,"twenty":-31.317968,"median":-3.043901,"eighty":-1.523371,"marketCap":218313708},{"date":"2023-06-02","current":-2.1164,"twenty":-31.075244,"median":-3.001445,"eighty":-1.524524,"marketCap":232894958},{"date":"2023-06-09","current":-2.410855,"twenty":-30.978154,"median":-2.940357,"eighty":-1.530348,"marketCap":265297735},{"date":"2023-06-16","current":-3.342071,"twenty":-30.942849,"median":-2.978468,"eighty":-1.535157,"marketCap":367771516},{"date":"2023-06-23","current":-3.062338,"twenty":-30.90313,"median":-3.001445,"eighty":-1.538886,"marketCap":336988878},{"date":"2023-06-30","current":-3.244533,"twenty":-30.870032,"median":-3.001445,"eighty":-1.544764,"marketCap":357038096},{"date":"2023-07-07","current":-3.323668,"twenty":-30.870032,"median":-3.043901,"eighty":-1.550754,"marketCap":365746343},{"date":"2023-07-14","current":-3.209566,"twenty":-30.847966,"median":-3.079964,"eighty":-1.550754,"marketCap":353190267},{"date":"2023-07-21","current":-3.290541,"twenty":-30.572144,"median":-3.095464,"eighty":-1.551022,"marketCap":362101030},{"date":"2023-07-28","current":-3.088103,"twenty":-30.516979,"median":-3.150675,"eighty":-1.556458,"marketCap":339824121},{"date":"2023-08-04","current":-3.408323,"twenty":-30.494914,"median":-3.183801,"eighty":-1.556458,"marketCap":375062141},{"date":"2023-08-11","current":-4.28135,"twenty":-30.483881,"median":-3.202219,"eighty":-1.558388,"marketCap":416489682},{"date":"2023-08-18","current":-3.714451,"twenty":-30.461815,"median":-3.220608,"eighty":-1.559159,"marketCap":361341839},{"date":"2023-08-25","current":-3.955595,"twenty":-29.976368,"median":-3.226129,"eighty":-1.563362,"marketCap":384800250},{"date":"2023-09-01","current":-4.294041,"twenty":-29.799841,"median":-3.23165,"eighty":-1.566533,"marketCap":417724336},{"date":"2023-09-08","current":-4.848248,"twenty":-29.499747,"median":-3.272138,"eighty":-1.567359,"marketCap":471637526},{"date":"2023-09-15","current":-5.140158,"twenty":-29.398244,"median":-3.290541,"eighty":-1.568282,"marketCap":500034550},{"date":"2023-09-22","current":-6.723158,"twenty":-29.365146,"median":-3.323668,"eighty":-1.574468,"marketCap":654028850},{"date":"2023-09-29","current":-7.254081,"twenty":-29.093736,"median":-3.329649,"eighty":-1.579332,"marketCap":705677014},{"date":"2023-10-06","current":-7.108776,"twenty":-29.0143,"median":-3.33655,"eighty":-1.580231,"marketCap":691541727},{"date":"2023-10-13","current":-6.561087,"twenty":-28.93707,"median":-3.364155,"eighty":-1.580781,"marketCap":638262569},{"date":"2023-10-20","current":-5.884859,"twenty":-28.83998,"median":-3.393601,"eighty":-1.582043,"marketCap":572479118},{"date":"2023-10-27","current":-7.181429,"twenty":-28.83998,"median":-3.404643,"eighty":-1.582976,"marketCap":698609370},{"date":"2023-11-03","current":-8.796551,"twenty":-28.778196,"median":-3.414978,"eighty":-1.585216,"marketCap":855728521},{"date":"2023-11-10","current":-9.183057,"twenty":-28.531059,"median":-3.488347,"eighty":-1.588578,"marketCap":882142780},{"date":"2023-11-17","current":-9.541281,"twenty":-28.522233,"median":-3.577635,"eighty":-1.590373,"marketCap":916554542},{"date":"2023-11-24","current":-7.960544,"twenty":-28.486927,"median":-3.714451,"eighty":-1.597553,"marketCap":764705816},{"date":"2023-12-01","current":-7.932114,"twenty":-28.3435,"median":-3.818505,"eighty":-1.597628,"marketCap":761974723},{"date":"2023-12-08","current":-6.629996,"twenty":-28.288335,"median":-3.921888,"eighty":-1.604472,"marketCap":636890701},{"date":"2023-12-15","current":-7.005279,"twenty":-28.166973,"median":-3.930325,"eighty":-1.604472,"marketCap":672941118},{"date":"2023-12-22","current":-7.625064,"twenty":-28.155941,"median":-3.948568,"eighty":-1.609186,"marketCap":732478928},{"date":"2023-12-29","current":-8.239163,"twenty":-28.109602,"median":-3.95348,"eighty":-1.614472,"marketCap":791470519},{"date":"2024-01-05","current":-7.096257,"twenty":-28.065471,"median":-3.968578,"eighty":-1.622093,"marketCap":681680613},{"date":"2024-01-12","current":-6.527646,"twenty":-27.977208,"median":-4.0254,"eighty":-1.638882,"marketCap":627058769},{"date":"2024-01-19","current":-6.374122,"twenty":-27.835987,"median":-4.111281,"eighty":-1.640482,"marketCap":612310871},{"date":"2024-01-26","current":-6.533333,"twenty":-27.703592,"median":-4.171354,"eighty":-1.640482,"marketCap":627604987},{"date":"2024-02-02","current":-8.72327,"twenty":-27.637395,"median":-4.255382,"eighty":-1.640482,"marketCap":837974720},{"date":"2024-02-09","current":-8.72327,"twenty":-27.482934,"median":-4.288732,"eighty":-1.642473,"marketCap":837974720},{"date":"2024-02-16","current":-8.471582,"twenty":-27.471901,"median":-4.372816,"eighty":-1.643211,"marketCap":813797089},{"date":"2024-02-23","current":-7.710798,"twenty":-27.471901,"median":-4.404546,"eighty":-1.649935,"marketCap":740714703},{"date":"2024-03-01","current":-7.093019,"twenty":-27.26007,"median":-4.484417,"eighty":-1.657755,"marketCap":681369608},{"date":"2024-03-08","current":-8.048289,"twenty":-27.074717,"median":-4.574398,"eighty":-1.659876,"marketCap":773134709},{"date":"2024-03-15","current":-6.693224,"twenty":-27.023966,"median":-4.775633,"eighty":-1.660395,"marketCap":646933553},{"date":"2024-03-22","current":-6.681654,"twenty":-27.010727,"median":-4.879016,"eighty":-1.66369,"marketCap":645815258},{"date":"2024-03-28","current":-6.47918,"twenty":-26.99528,"median":-4.962473,"eighty":-1.675511,"marketCap":626245099},{"date":"2024-04-05","current":-6.080016,"twenty":-26.887158,"median":-5.075777,"eighty":-1.686808,"marketCap":587663927},{"date":"2024-04-12","current":-6.681654,"twenty":-26.814341,"median":-5.188809,"eighty":-1.696965,"marketCap":645815258},{"date":"2024-04-19","current":-5.727132,"twenty":-26.723871,"median":-5.409271,"eighty":-1.704543,"marketCap":553555935},{"date":"2024-04-26","current":-5.686637,"twenty":-26.620162,"median":-5.718454,"eighty":-1.706728,"marketCap":549641904},{"date":"2024-05-03","current":-5.827465,"twenty":-26.569411,"median":-5.758022,"eighty":-1.70792,"marketCap":563253637},{"date":"2024-05-10","current":-5.536514,"twenty":-26.542931,"median":-5.806223,"eighty":-1.712194,"marketCap":549991794},{"date":"2024-05-17","current":-5.435237,"twenty":-26.474527,"median":-5.744487,"eighty":-1.717177,"marketCap":539930968},{"date":"2024-05-24","current":-4.911968,"twenty":-26.41495,"median":-5.715984,"eighty":-1.721379,"marketCap":487950036},{"date":"2024-05-31","current":-5.41273,"twenty":-26.397298,"median":-5.614389,"eighty":-1.72446,"marketCap":537695229},{"date":"2024-06-07","current":-7.47767,"twenty":-26.214152,"median":-5.709777,"eighty":-1.726559,"marketCap":742824282},{"date":"2024-06-14","current":-7.010667,"twenty":-25.940536,"median":-5.727132,"eighty":-1.7267,"marketCap":696432698},{"date":"2024-06-21","current":-6.425507,"twenty":-25.905231,"median":-5.758022,"eighty":-1.727263,"marketCap":638303484},{"date":"2024-06-28","current":-6.30735,"twenty":-25.883165,"median":-5.784982,"eighty":-1.729362,"marketCap":626565854},{"date":"2024-07-05","current":-6.003517,"twenty":-25.746357,"median":-5.836143,"eighty":-1.733496,"marketCap":596383378},{"date":"2024-07-12","current":-7.033174,"twenty":-25.078757,"median":-5.882203,"eighty":-1.738766,"marketCap":698668437},{"date":"2024-07-15","current":-6.920643,"twenty":-24.825995,"median":-5.884859,"eighty":-1.740093,"marketCap":687489742},{"date":"2024-08-02","current":-9.261283,"twenty":-24.573232,"median":-5.885097,"eighty":-1.741419,"marketCap":920006598},{"date":"2024-08-09","current":-6.650423,"twenty":-23.992471,"median":-5.922852,"eighty":-1.75225,"marketCap":729059316},{"date":"2024-08-16","current":-6.467719,"twenty":-23.921891,"median":-6.003517,"eighty":-1.759611,"marketCap":709030214},{"date":"2024-08-23","current":-6.01879,"twenty":-23.731204,"median":-6.018435,"eighty":-1.763065,"marketCap":659815849},{"date":"2024-08-30","current":-6.02923,"twenty":-23.589644,"median":-6.02401,"eighty":-1.764859,"marketCap":660960369},{"date":"2024-09-06","current":-6.175393,"twenty":-23.5677,"median":-6.02401,"eighty":-1.767614,"marketCap":676983650},{"date":"2024-09-13","current":-6.185833,"twenty":-23.539487,"median":-6.080016,"eighty":-1.772239,"marketCap":678128171},{"date":"2024-09-20","current":-7.099353,"twenty":-23.498734,"median":-6.09668,"eighty":-1.775172,"marketCap":778273681},{"date":"2024-09-27","current":-6.378978,"twenty":-23.467386,"median":-6.129618,"eighty":-1.784148,"marketCap":699301793},{"date":"2024-10-04","current":-6.03445,"twenty":-23.432903,"median":-6.146644,"eighty":-1.794098,"marketCap":661532629},{"date":"2024-10-11","current":-5.825646,"twenty":-23.406256,"median":-6.109202,"eighty":-1.794504,"marketCap":638642226},{"date":"2024-10-18","current":-6.425959,"twenty":-23.401554,"median":-6.125802,"eighty":-1.794826,"marketCap":704452133},{"date":"2024-10-25","current":-6.117972,"twenty":-23.360801,"median":-6.129618,"eighty":-1.795797,"marketCap":670688790},{"date":"2024-10-31","current":-6.070991,"twenty":-23.276161,"median":-6.129618,"eighty":-1.799329,"marketCap":665538449},{"date":"2024-11-08","current":-6.47294,"twenty":-23.171143,"median":-6.146644,"eighty":-1.810933,"marketCap":709602474},{"date":"2024-11-15","current":-4.713934,"twenty":-23.124121,"median":-6.133555,"eighty":-1.813276,"marketCap":578300679},{"date":"2024-11-22","current":-3.673135,"twenty":-23.111582,"median":-6.125802,"eighty":-1.816307,"marketCap":450616469},{"date":"2024-11-29","current":-4.723268,"twenty":-23.111582,"median":-6.113587,"eighty":-1.816534,"marketCap":579445829},{"date":"2024-12-06","current":-4.797944,"twenty":-23.056722,"median":-6.096269,"eighty":-1.81972,"marketCap":588607028},{"date":"2024-12-13","current":-3.136399,"twenty":-23.025374,"median":-6.080723,"eighty":-1.81972,"marketCap":384770352},{"date":"2024-12-20","current":-2.702344,"twenty":-22.970514,"median":-6.065771,"eighty":-1.820535,"marketCap":331520884},{"date":"2024-12-27","current":-2.949709,"twenty":-22.964244,"median":-6.03624,"eighty":-1.820535,"marketCap":361867355},{"date":"2025-01-03","current":-2.599664,"twenty":-22.939165,"median":-6.02923,"eighty":-1.820535,"marketCap":318924236},{"date":"2025-01-10","current":-3.477925,"twenty":-22.876469,"median":-6.01879,"eighty":-1.822136,"marketCap":426668331},{"date":"2025-01-17","current":-3.193642,"twenty":-22.774587,"median":-6.003517,"eighty":-1.825707,"marketCap":391792832},{"date":"2025-01-24","current":-3.53841,"twenty":-22.704053,"median":-5.990273,"eighty":-1.827693,"marketCap":434088649},{"date":"2025-01-31","current":-3.828742,"twenty":-22.594334,"median":-5.957512,"eighty":-1.834402,"marketCap":469706180},{"date":"2025-02-07","current":-3.780353,"twenty":-22.53007,"median":-5.92384,"eighty":-1.857836,"marketCap":463769925},{"date":"2025-02-14","current":-2.921457,"twenty":-22.501856,"median":-5.914388,"eighty":-1.859317,"marketCap":358401398},{"date":"2025-02-21","current":-3.072671,"twenty":-22.414081,"median":-5.884859,"eighty":-1.860547,"marketCap":376952195},{"date":"2025-02-28","current":-2.667417,"twenty":-22.390569,"median":-5.874802,"eighty":-1.860547,"marketCap":327236059},{"date":"2025-03-07","current":-2.715806,"twenty":-22.33571,"median":-5.827465,"eighty":-1.86056,"marketCap":333172314},{"date":"2025-03-14","current":-2.643223,"twenty":-22.33571,"median":-5.771502,"eighty":-1.864548,"marketCap":324267931},{"date":"2025-03-21","current":-2.174431,"twenty":-22.312198,"median":-5.727132,"eighty":-1.866702,"marketCap":281532227},{"date":"2025-03-28","current":-2.216653,"twenty":-21.990878,"median":-5.698207,"eighty":-1.879271,"marketCap":286998873},{"date":"2025-04-04","current":-1.768044,"twenty":-21.943855,"median":-5.536514,"eighty":-1.864548,"marketCap":228915767},{"date":"2025-04-11","current":-1.799711,"twenty":-21.943855,"median":-5.440863,"eighty":-1.85901,"marketCap":233015751},{"date":"2025-04-17","current":-2.248319,"twenty":-21.881158,"median":-5.42117,"eighty":-1.86024,"marketCap":291098856}],"updateTime":1745263640511}}}